{
    "2021-06-01": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "FDA approval",
                        "children",
                        "adolescents",
                        "plaque psoriasis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Novartis Terminates Three Beovu Studies in Ocular Disorders Citing Patient Safety",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Beovu",
                        "Terminates",
                        "Studies",
                        "Patient Safety",
                        "Ocular Disorders"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}